Shape the market access strategy for tomorrow's therapies – and help ensure life-changing treatments reach the patients who need them most. If you thrive at the intersection of strategy, science and stakeholder influence, this is your opportunity to make a global impact from the earliest stages of asset development.

Your new role
As Global Market Access Lead, you will drive asset evaluation and access planning for early-stage assets, becoming the market access voice in pipeline decisions that shape Novo Nordisk's future portfolio. You'll combine strategic thinking, health economics expertise and cross-functional collaboration to translate scientific innovation into patient access at scale.

Your key responsibilities will include: